Martin Szelagiewicz
39Patents
7h-index
44Co-inventors
69Inventor score
Filing activity: Sep 8, 1998 → Jul 28, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9884857B2 | Salts of dasatinib in amorphous form | Chemistry; Metallurgy | 13 | Active |
| US6939992B2 | Polymorphic forms of sertraline hydrochloride | Chemistry; Metallurgy | 12 | Expired |
| US7442838B2 | Polymorphic forms of sertraline hydrochloride | Chemistry; Metallurgy | 11 | Expired |
| US6872853B1 | Polymorphic forms of sertraline hydrochloride | Chemistry; Metallurgy | 11 | Expired |
| US6696479B2 | Crystalline forms | Human Necessities | 10 | Expired |
| US9556164B2 | Salts of Dasatinib in crystalline form | Chemistry; Metallurgy | 7 | Active |
| US9340536B2 | Multicomponent crystals comprising dasatinib and selected co-crystal formers | Chemistry; Metallurgy | 7 | Active |
| US9567317B2 | Multicomponent crystalline system comprising nilotinib and selected co-crystal formers | Human Necessities | 6 | Active |
| US8841316B2 | Multicomponent crystalline system of rosuvastatin calcium salt and vanillin | Chemistry; Metallurgy | 3 | Active |
| US8716305B2 | Multicomponent crystalline system of rosuvastatin calcium salt and vanillin | Chemistry; Metallurgy | 3 | Active |
| US9290452B2 | Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof | Chemistry; Metallurgy | 2 | Active |
| US6455556B2 | Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide | Human Necessities | 2 | Expired |
| US7932387B2 | Crystalline forms of rosuvastatin calcium salt | Human Necessities | 2 | Active |
| US6858643B2 | Crystalline forms of Fluvastatin sodium | Human Necessities | 2 | Expired |
| US7892354B2 | Process for the parallel detection of crystalline forms of molecular solids | Emerging Cross-Sectional Technologies | 1 | Active |
| US11925644B2 | Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and l-leucine ethyl ester | Chemistry; Metallurgy | 1 | Active |
| US8557993B2 | Crystalline forms of pitavastatin calcium | Chemistry; Metallurgy | 1 | Active |
| US7504071B2 | Sealing system with flow channels | Physics | 1 | Expired |
| US8076362B2 | Crystal modification A of 1-(2,6-difluorobenzyI)-1 H-1,2,3-triazole-4-carboxamide and dosage forms and formulations thereof | Human Necessities | 1 | Active |
| US11992491B2 | Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester | Human Necessities | 1 | Active |
| US7432380B2 | Crystalline form of Fluvastatin sodium | Human Necessities | 1 | Expired |
| US8853405B2 | Crystalline forms of pitavastatin calcium | Chemistry; Metallurgy | 1 | Active |
| US6740669B1 | Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic | Human Necessities | 1 | Expired |
| US6906087B2 | Crystalline forms of venlafaxine hydrochloride | Chemistry; Metallurgy | 1 | Expired |
| US12221446B2 | Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.